Elegen
Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.
Currently, there are no issues on this topic.
Find more companies like Elegen
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
